VIPAS39: VPS33B Interacting Protein, Apical-Basolateral Polarity Regulator, Spe-39 Homolog

Key regulator of endosomal-lysosomal trafficking and epithelial cell polarity; associated with ARC syndrome and related disorders.

Gene Information Card

Symbol VIPAS39
Full Name VPS33B Interacting Protein, Apical-Basolateral Polarity Regulator, Spe-39 Homolog
Gene Type Protein coding
Chromosomal Location 14q31.3
NCBI Gene ID 63894 ncbi.nlm.nih.gov/gene/63894
Ensembl ID ENSG00000100823
UniProt ID Q9H9C1
OMIM ID 613401
HGNC ID 20347
Aliases SPE-39, hSPE-39, VIPAR, VPS33B-interacting protein, apical-basolateral polarity regulator

Description

VIPAS39 (VPS33B Interacting Protein, Apical-Basolateral Polarity Regulator, Spe-39 Homolog) encodes a protein that interacts with VPS33B to regulate endosomal-lysosomal trafficking and maintain apical-basolateral polarity in epithelial cells. The protein is part of the HOPS (homotypic fusion and protein sorting) complex and is essential for proper lysosome biogenesis and function. Mutations in VIPAS39 cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome, a severe multisystem disorder.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome Loss-of-function mutations disrupt endosomal-lysosomal trafficking, leading to impaired bile acid secretion, renal tubular dysfunction, and joint contractures. ClinVar, OMIM
Cholestasis, progressive familial intrahepatic 9 Defects in VIPAS39 impair bile canalicular formation and bile acid transport. OMIM #619849

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 10.2 Medium
Small intestine 8.9 Medium
Pancreas 7.3 Low
Brain 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 14.8 Hepatocyte model
HEK 293 (embryonic kidney) 11.3 Epithelial cell line
Caco-2 (colon) 9.6 Intestinal epithelial model
SH-SY5Y (neuroblastoma) 4.2 Neuronal model
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.743G>A (p.Arg248Gln) Missense Rare Loss of VPS33B interaction; causes ARC syndrome
c.1A>G (p.Met1?) Start loss Rare Complete loss of protein; ARC syndrome
c.112C>T (p.Arg38*) Nonsense Rare Premature truncation; ARC syndrome
c.497_498del (p.Val166Alafs*5) Frameshift Rare Loss of function; ARC syndrome
Mutation functional classification

Loss of Function (LOF)

Most reported mutations are loss-of-function (nonsense, frameshift, start loss, missense disrupting VPS33B binding), leading to ARC syndrome.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported; inheritance is autosomal recessive.

Pathways

Endosomal-lysosomal trafficking (HOPS complex)
Apical-basolateral polarity establishment
Lysosome biogenesis

Protein Summary

VIPAS39 (SPE-39) is a 492-amino acid protein that localizes to endosomes and lysosomes. It directly binds VPS33B, a class C VPS protein, to form a complex essential for endosome-lysosome fusion and lysosomal maturation. The protein also regulates epithelial cell polarity by controlling the trafficking of apical and basolateral membrane proteins. Loss of VIPAS39 function leads to defective bile canaliculi formation, renal tubular dysfunction, and impaired joint development, characteristic of ARC syndrome.

Related Products

Product name Cat.No. Species Gene ID
VIPAS39 Knockout HEK293 Cell Line EDJ-KQ15317 Human 63894 Details Get a Quote
VIPAS39 Knockout A-549 Cell Line EDJ-KQ47251 Human 63894 Details Get a Quote
VIPAS39 Knockout HCT 116 Cell Line EDJ-KQ47252 Human 63894 Details Get a Quote
VIPAS39 Knockout HeLa Cell Line EDJ-KQ47253 Human 63894 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: